Research page
Global Health Centre

Knowledge Network for Innovation and Access to Medicines

  • Project Director: Suerie Moon
  • Project Coordinator: Marcela Vieira
  • Research Assistants: Elise Erickson, Danielle Navarro
  • Project owner: The Global Health Centre at the Graduate Institute of International and Development Studies in Geneva
  • Project status: Ongoing
  • Key Words: access to medicines, pharmaceutical innovation, global health, research, information and evidence gaps, literature reviews

Project Description

Ensuring globally equitable innovation and access to medicines is a major challenge for global health governance, and is now recognized as a problem across high-, middle- and low-income countries.  Access to safe, effective, affordable medicines is a necessary component of universal health coverage; it can alleviate suffering, prevent disease and save lives.  However, high prices of effective new medicines can restrict patient access and threaten the sustainability of health systems. At the same time, many health technologies urgently needed to address public health needs have not been developed or offer limited benefit over the status quo. There is growing interest in new approaches to the research & development (R&D) of health technologies. Research, evidence and analysis are important for informing policymakers, analysts, advocates and the public about measures to address innovation and access challenges. However, such information is not always available, may not be easy to digest, nor readily translated into evidence-based policy. Significant gaps in the knowledge base persist. The Knowledge Network for Innovation and Access to Medicines was created to maximize the contributions of research and analysis to producing public health needs-driven innovation and globally-equitable access to medicines. It seeks to do so by:

  1. Making the existing knowledge base more widely available and accessible to policymakers, practitioners, advocates and the public;
  2. Identifying and helping to fill information and evidence gaps;
  3. Strengthening two-way flows of knowledge between the research and policy communities, including by engaging underrepresented voices.

The project has developed concise syntheses of the state of knowledge on various policies seeking to improve innovation and access to medicines, along with data sources. It organizes regular webinars presented by lead authors to make recent, policy-relevant research more accessible to a broad global public audience. And it convenes regular workshops and meetings to identify important information & evidence gaps, facilitate research collaborations, and strengthen networks.

This project is funded by a grant of the Open Society Foundations.

Knowledge Portal
Online tool providing open-access information, research and analysis on policies relating to pharmaceutical innovation and access


17 December 2019 | 16:00-17:00 CET
Regulating Drug Prices: National and Global Implications of Canada’s Recent Reforms

28 November 2019 | 16:00-17:00 CET
Public Funding of Biomedical R&D: What Role for Public Investment Funds and Financial Markets?

29 October 2019 | 16:00-17:00 CET
China’s Changing Role in the Global Pharmaceutical System: Implications for National and Global Public Health

26 September 2019 | 16:00-17:15 CEST
Is Data Exclusivity Justified? Evidence on the Impacts on Innovation and Access to Medicines

20 June 2019 | 16:00-17:00 CEST
Global Access to Affordable Insulin: Understanding the Barriers

25 April 2019 | 16:00-17:00 CEST
Public Funding of Drug Development: Contributions of the US NIH

21 March 2019 | 16:00-17:15 CET
R&D Costs of Cancer Medicines: How Does It Compare with Sales Income?

14 February 2019 | 16:00-17:00 CET
Regulation to Accelerate Access to Biosimilars: Colombia's Pioneering Approach

15 January 2019 | 16:00-17:00 CET
Using Competition Law to Address High Medicines Prices

13 December 2018 | 16:00-17:00 CET
Addressing High Drug Prices - What Can be Learned from European Policies?

20 November 2018 | 16:00-17:00 CET
New Technologies for Neglected Diseases: What is Likely to Come out of the Pipeline, What is Missing, and What Will it Cost?

16 October 2018 | 16:00-17:00 CET
A New World Patent Order: An Analysis of Granted and Rejected Bioemedical Patents in India - With Implications for Brazil, South Africa & Beyond